E-LIB Suche - Ergebnisse für: Thistlethwaite, Fiona C.

1

Delivery of adoptive cell therapy in the context of the hea..:

Pillai, Manon ; Davies, Michelle M. ; Thistlethwaite, Fiona C.
Therapeutic Advances in Vaccines and Immunotherapy. 8 (2020) - p. 251513552094435 , 2020

Link: https://doi.org/10.1177/..

2

A multidisciplinary-tailored digital solution to data captu..:

Graham, Donna M. ; Wickert, Gemma ; Goodwin, Leanna...
Journal of Global Oncology. 5 (2019) suppl - p. 2-2 , 2019

Link: https://doi.org/10.1200/..

3

The clinical efficacy of first-generation carcinoembryonic ..:

Thistlethwaite, Fiona C. ; Gilham, David E. ; Guest, Ryan D....
Cancer Immunology, Immunotherapy. 66 (2017) 11 - p. 1425-1436 , 2017

Link: https://doi.org/10.1007/..

4

Tremelimumab (anti-CTLA4) mediates immune responses mainly ..:

Khan, Sameena ; Burt, Deborah J. ; Ralph, Christy...
Clinical Immunology. 138 (2011) 1 - p. 85-96 , 2011

Link: https://doi.org/10.1016/..

5

Anti-angiogenic therapy in the treatment of advanced renal ..:

Board, Ruth E. ; Thistlethwaite, Fiona C. ; Hawkins, Robert E.
Cancer Treatment Reviews. 33 (2007) 1 - p. 1-8 , 2007

Link: https://doi.org/10.1016/..

6

Adoptive transfer of Treg depleted autologous T cells in ad..:

Thistlethwaite, Fiona C. ; Elkord, Eyad ; Griffiths, Richard W....
Cancer Immunology, Immunotherapy. 57 (2007) 5 - p. 623-634 , 2007

Link: https://doi.org/10.1007/..

7

Cellular therapy of cancer symposium December 2nd–3rd 2006 ..:

Thistlethwaite, Fiona C. ; Gilham, David E. ; Hawkins, Robert E.
Cancer Immunology, Immunotherapy. 56 (2007) 6 - p. 939-942 , 2007

Link: https://doi.org/10.1007/..

8

Killing of non‐Hodgkin lymphoma cells by autologous CD19 en..:

Cheadle, Eleanor J. ; Gilham, David E. ; Thistlethwaite, Fiona C...
British Journal of Haematology. 129 (2005) 3 - p. 322-332 , 2005

Link: https://doi.org/10.1111/..

9

Involvement of Brca2 in DNA Repair:

Patel, Ketan J ; Yu, Veronica P.C.C ; Lee, Hyunsook...
Molecular Cell. 1 (1998) 3 - p. 347-357 , 1998

Link: https://doi.org/10.1016/..

10

Clinical feasibility and treatment outcomes with nonselecte..:

Pillai, Manon ; Jiang, Yizhou ; Lorigan, Paul C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441996/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Tisotumab Vedotin in Previously Treated Recurrent or Metast..:

Hong, David S ; Concin, Nicole ; Vergote, Ignace...
boreal:224197. , 2020

Link: http://hdl.handle.net/20..

12

Tisotumab Vedotin in Previously Treated Recurrent or Metast..:

Hong, David S ; Concin, Nicole ; Vergote, Ignace...
Hong , D S , Concin , N , Vergote , I , de Bono , J S , Slomovitz , B M , Drew , Y , Arkenau , H T , Machiels , J P , Spicer , J F , Jones , R , Forster , M D , Cornez , N , Gennigens , C , Johnson , M L , Thistlethwaite , F C , Rangwala , R A , Ghatta , S , Windfeld , K , Harris , J R , Lassen , U N & Coleman , R L 2020 , ' Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer ' , Clinical cancer research : an official journal of the American Association for Cancer Research , vol. 26 , no. 6 , pp. 1220-1228 . https://doi.org/10.1158/1078-0432.CCR-19-2962. , 2020

Link: https://kclpure.kcl.ac.u..

13

Delivery of adoptive cell therapy in the context of the hea..:

Pillai, Manon ; Davies, Michelle M ; Thistlethwaite, Fiona C
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509731/. , 2020

Link: http://www.ncbi.nlm.nih...

14

Tisotumab Vedotin in Previously Treated Recurrent or Metast..:

Hong, David S ; Concin, Nicole ; Vergote, Ignace...
Hong , D S , Concin , N , Vergote , I , de Bono , J S , Slomovitz , B M , Drew , Y , Arkenau , H T , Machiels , J P , Spicer , J F , Jones , R , Forster , M D , Cornez , N , Gennigens , C , Johnson , M L , Thistlethwaite , F C , Rangwala , R A , Ghatta , S , Windfeld , K , Harris , J R , Lassen , U N & Coleman , R L 2020 , ' Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer ' , Clinical cancer research : an official journal of the American Association for Cancer Research , vol. 26 , no. 6 , pp. 1220-1228 . https://doi.org/10.1158/1078-0432.CCR-19-2962. , 2020

Link: https://kclpure.kcl.ac.u..

15

Tisotumab vedotin in patients with advanced or metastatic s..:

De Bono, Johann S ; Concin, Nicole ; Hong, David S...
De Bono , J S , Concin , N , Hong , D S , Thistlethwaite , F C , Machiels , J , Arkenau , H , Plummer , R , Jones , R H , Nielsen , D , Windfeld , K , Ghatta , S , Slomovitz , B M , Spicer , J F , Yachnin , J , Ang , J E , Mau-sørensen , P M , Forster , M D , Collins , D , Dean , E , Rangwala , R A & Lassen , U 2019 , ' Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201) : a first-in-human, multicentre, phase 1–2 trial ' , The Lancet Oncology , vol. 20 , no. 3 , pp. 383-393 . https://doi.org/10.1016/S1470-2045(18)30859-3. , 2019

Link: https://kclpure.kcl.ac.u..